Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Clinical trial NCT00831545 · COMPLETED

Trial details

NCT number: NCT00831545
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastases of Central Nervous System Melanoma Breast Neoplasm Carcinoma, Non-Small-Cell Lung

Start date: 2000-12-01
Primary completion: 2006-10-20
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.